Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  FIRST NORTH STOCKHOLM  >  Biovica International AB (publ)    BIOVIC B   SE0008613731

BIOVICA INTERNATIONAL AB (PUBL)

(BIOVIC B)
  Report  
SummaryQuotesChartsNewsCalendarCompanyFinancialsConsensusRevisions 
Business Summary
Logo Biovica International AB (
Biovica International AB is a Sweden-based biotechnology company. It develops and commercializes blood-based biomarker assays for the monitoring of cancer therapies and for prediction of patient outcome. The Company has focus on breast cancer and its main product DiviTum is a blood-based test, which measures the activity of the enzyme thymidine kinase-1 (TK) in blood serum or cell cultures. The Company collaborates with numerous institutions, such as Karolinska Institutet in Sweden and Dana Farber Cancer Institute, Washington University, Baylor College of Medicine, City of Hope Research & Treatment Center in the Unites States, as well as The International Breast Cancer Study Group (IBCSG) based in Switzerland and Breast International Group in Belgium.

Number of employees : 17 people.
Sales per Businesses
20182019Delta
SEK (in Million)%SEK (in Million)%
Biomarkers2.0173.7%2.9497.9% +46.66%
Other0.54920.2%0.0632.1% -88.52%
Services0.1686.2%---
Sales per Regions
20182019Delta
SEK (in Million)%SEK (in Million)%
United States2.1378.4%1.9163.5% -10.54%
Sweden0.52719.4%0.0632.1% -88.05%
European Union excluding Sweden0.0451.7%1.0233.8% +2157.78%
Asia0.0170.6%0.0170.6% 0%
Managers
NameAgeSinceTitle
Anders Rylander482011Chief Executive Officer & Director
Lars Erik Holmqvist602019Chairman
Adam Germunder34-Operations Director
Cecilia Driving472016Chief Financial Officer
Karin Mattsson, Dr.482017Director-Research & Development
Mattias Bergqvist48-Director-Clinical Development
Jarl Ulf Birger Jungnelius, Dr.672014Independent Director
Maria Holmlund622016Independent Director
Jesper Söderqvist, Dr.522013Independent Director
Henrik Osvald-2019Director
Equities
Vote QuantityFloatCompany-owned sharesTotal Float
Stock A 1 16,279,684 16,275,934 100.0% 0 0.0% 69.0%
Stock B 0 7,293,688 0 0.0% 0 0.0%
Shareholders
NameEquities%
Ålandsbanken Fondbolag AB (Sweden) 339,117 2.08%
Company contact information
Biovica International AB
Dag Hammarskjölds väg 54B
Uppsala Science Park
Uppsala 752 37

Phone : +46.18.44.44.830
Fax : +46.18.57.24.28
Web : http://www.biovica.com
Sector Bio Diagnostics & Testing
1st jan.Capitalization (M$)
BIOVICA INTERNATIONAL AB (PUBL)34.52%28
GUARDANT HEALTH, INC.96.81%6 947
GENSCRIPT BIOTECH CORPORATION87.81%4 694
IOVANCE BIOTHERAPEUTICS, INC.179.32%3 120
INVITAE CORPORATION59.95%1 707
VERACYTE, INC.131.96%1 425
MIRACA HOLDINGS INC.11.27%1 418
CAREDX, INC-15.63%900
SEEGENE INC--.--%605
INNATE PHARMA-23.74%492
Q-LINEA AB (PUBL)-9.92%131
EPIGENOMICS AG-16.33%69
LYSOGENE-1.88%23